Enzon Pharmaceuticals Inc (ENZN) Financial Statements (2026 and earlier)

Company Profile

Business Address	333 EAST BUTTERFIELD ROAD, SUITE 400 LOMBARD, IL 60148
State of Incorp.	DE
Fiscal Year End	December 31
Industry (SIC)	2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info	Complete Financial Analysis Financial Benchmarking

	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments	42,574	46,859	47,012	46,982	47,641	48,142
Cash and cash equivalent	42,574	46,859	47,012	46,982	47,641	48,142
Receivables
Inventory, net of allowances, customer advances and progress billings
Inventory
Other current assets	239	293	331	405	85	59
Other undisclosed current assets						31
Total current assets:	42,813	47,152	47,343	47,387	47,726	48,232
Noncurrent Assets
Operating lease, right-of-use asset
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization
Intangible asset, including goodwill, after accumulated amortization
Goodwill
Intangible asset, excluding goodwill, after accumulated amortization
Deferred income tax assets		17	359	202
Other noncurrent assets
Other undisclosed noncurrent assets
Total noncurrent assets:		17	359	202
Other undisclosed assets					28
TOTAL ASSETS:	42,813	47,169	47,702	47,589	47,754	48,232
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities	731	403	439	424	403	412
Accounts payable	331	331	331	331	331	302